Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
Allergy. 2022 May 23;77(9):2852-6. doi: 10.1111/all.15385. Online ahead of print.
Allergy. 2022.
PMID: 35603478
Free PMC article.
No abstract available.